ADVERTISEMENT

 

Press Releases

 

3

May

2023

Provider Status Alert: Maryland pharmacists can now bill for their services

Author: James Keagy

ANNAPOLIS, MD, and WASHINGTON, DC—The Maryland Pharmacists Association (MPhA), Maryland Pharmacy Coalition (MPC), and American Pharmacists Association (APhA) are proud to announce that Maryland pharmacists will soon have expanded ability to bill for certain health care services.

Comments (0)
Number of views (7286)
Article rating: No rating

27

Apr

2023

APhA selects permanent CEO

Author: James Keagy

(WASHINGTON, DC) Today, the American Pharmacists Association (APhA) announced that Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, has been named the 15th Chief Executive Officer and Executive Vice President of APhA.

Comments (0)
Number of views (10318)
Article rating: No rating

14

Apr

2023

APhA applauds HHS for extending PREP Act authorities for pharmacy personnel

Author: James Keagy

The American Pharmacists Association (APhA) commends the U.S. Department of Health and Human Services (HHS) for announcing that they will ensure that patients can continue to get COVID-19–related care from their pharmacists. APhA is grateful that HHS listened to the concerns of APhA and others in the pharmacy community in expressing a need for HHS to clarify the role of pharmacists and pharmacy teams when the public health emergency expires on May 11, 2023.

Comments (0)
Number of views (8110)
Article rating: No rating

24

Mar

2023

More Than 190 Groups Applaud Bipartisan Federal Legislation to Ensure Senior Access to Essential Pharmacist Services & Strengthen Our Nation’s Public Health Response

Author: James Keagy

H.R. 1770 Would Provide Payment for Pharmacist Services for COVID-19, Flu, Strep & RSV Under Medicare Part B and Ensure Pharmacists Can Continue to Protect Vulnerable Senior Communities

Comments (0)
Number of views (7744)
Article rating: No rating

20

Mar

2023

APhA applauds new federal bipartisan PBM legislation

The American Pharmacists Association (APhA) applauds the introduction of the Drug Price Transparency in Medicaid Act, which would reign in PBMs’ unfair and anticompetitive business practices that are harming the viability of our nation’s pharmacies.

Comments (0)
Number of views (2813)
Article rating: No rating
RSS
First7891012141516Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT